TF and neoplasm: Strikingly, our analysis of the KPF-TF model indicated that the FSP-Cre transgene used targeted only ∼20% of overall aSMA+ CAFs in the STAT3cKO model, which was still sufficient to reveal the dramatic differences in survival and tumor characteristics compared with KPF alone.